Client News

Abivax announces German regulatory approval of ABX464 Covid-19 Phase 2b/3 COVID-19 clinical trial

InflaRx Reports Q1 2020 Financial & Operating Results

Simple and rapid SARS-CoV-2 diagnostic test project with 4basebio’s contribution receives funding from “la Caixa” Banking Foundation

Rentschler Biopharma licenses Horizon Discovery’s CHOSOURCE platform to complement cell line development offering for difficult-to-express proteins

GBA Group Pharma: LKF focuses on SARS-CoV-2 analysis: Ongoing COVID-19 testing to maintain clinical studies

APEIRON Biologics announces financing round for the further development of the COVID-19 drug APN01

Abivax SA: €36 million non-dilutive funding from Bpifrance for Abivax’ ABX464 Covid-19 program

AiCuris unterstützt das Land NRW bei der COVID-19 Ausbruchsbekämpfung in Schlachtbetrieben

Verona Pharma Announces FDA Response to End-of-Phase 2 Briefing Package for Ensifentrine in COPD and Outlines Phase 3 ENHANCE Clinical Program

Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial